modalities

Over the past several decades, drug development has expanded from traditional small-molecule chemicals to a diverse array of therapeutic modalities. These include biologics such as monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), nucleic acid-based therapies (siRNA, antisense oligonucleotides, mRNA vaccines), gene and cell therapies (including gene editing), and radiopharmaceuticals. In this deep dive, we explore the […]